DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




More Industry Headlines

Head of IBM Watson Health out after three hard years John Kelly, senior VP for Cognitive Solutions and IBM Research will lead Watson

FDA, DHS in new cybersecurity partnership Creating a new framework for coordinating better device safety

Novartis to acquire Endocyte for $2.1 billion Marks entrance into prostate cancer treatment

Siemens Healthineers expanding in Shanghai Investing $430 million in initiative that should create roughly 500 jobs

13-year-old creates algorithm to target pancreas during MR radiotherapy Bringing AI to a difficult cancer

At ASTRO, Varian introduces smaller footprint proton system, talks ‘flash’ therapy ProBeam 360° cuts irradiation time by 75 percent

A dose of sophistication comes to CT protocols In 2018, dose optimization means getting everyone involved

Envision Healthcare acquires Decatur Radiology Physicians Expands operations into central Illinois

ASTRO Product Showcase Here are some of the solutions you'll want to check out on the ASTRO exhibit floor

Radiation oncology stakeholders flock to San Antonio for ASTRO Radiation oncology's biggest event is finally upon us

Gingrich calls for
more medical device
price transparency.

Gingrich calls for medical device price transparency

by Brendon Nafziger , DOTmed News Associate Editor
Only Newt Gingrich knows if he intends to run for president on the Republican ticket next year. But the former speaker of the House has entered the medical device price transparency wars with an op-ed calling for Congress to ban exclusivity agreements between device makers and hospitals that accept Medicare or Medicaid.

In a syndicated column last week, Gingrich said that the lack of price transparency for medical devices was contributing to the "insolvency" of the government-run health programs.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!

The potential 2012 presidential contender said medical devices, such as hip implants and stents, are one of the few areas of U.S. health care where the prices aren't publicly available, and that the federal government and consumers can't know if prices have been marked up "hundreds of percentage points."

Medical device manufacturers often require hospitals to sign confidentiality agreements preventing them from revealing the price they paid for medical devices, Gingrich said, making "true price competition in the $153 billion medical-device marketplace impossible."

"Today we can shop -- often online -- and compare the price of a new car or a month's supply of blood pressure medication or a pair of blue jeans," Gingrich wrote. "We also, as health care consumers, can determine whether a generic drug or a brand name best serves our needs. But we are barred from comparing the quality, medical outcomes or price of an artificial hip or knee."

Gingrich, who is rumored to be announcing his presidential bid as early as this week, cited a 2009 report from the consulting firm McKinsey Global Institute that found hip implants cost 60 percent more in the United States than in the United Kingdom, Germany, France and Italy because of the lack of pricing transparency.

A 2007 bill introduced by the Republican Senators Charles Grassley, from Iowa, and Arlen Specter, from Pennsylvania, that would have required makers of implantable devices to report sales data to the government, fizzled in Congress.

The call for price transparency comes as Gingrich, who founded the think tank the Center for Health Transformation, tries to position himself as something of a health care policy wonk. At a Brookings Institution talk on medical innovation a little over a week ago, Gingrich argued for finding ways to speed up getting advanced medical products to market, such as allowing the Food and Drug Administration to grant conditional approvals.


You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.